{"id":"placebo-mifepristone","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL3188048","moleculeType":"Small molecule","molecularWeight":"429.60"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Placebo mifepristone is an inert control product used in clinical research and trials. It contains no active mifepristone and produces no therapeutic effect, serving as a comparator to evaluate the efficacy and safety of active mifepristone in study populations.","oneSentence":"This is a placebo formulation with no active pharmacological mechanism.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:01:09.440Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT05177510","phase":"PHASE2","title":"Mifepristone Outpatient Labour Induction","status":"RECRUITING","sponsor":"Chelsea and Westminster NHS Foundation Trust","startDate":"2023-08-25","conditions":"Labor, Induced","enrollment":400},{"nctId":"NCT02788981","phase":"PHASE2","title":"Abraxane® With or Without Mifepristone for Advanced, Glucocorticoid Receptor-Positive, Triple-Negative Breast Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Chicago","startDate":"2017-03-28","conditions":"Breast Cancer","enrollment":29},{"nctId":"NCT02989662","phase":"PHASE1, PHASE2","title":"INIA Stress and Chronic Alcohol Interactions: Glucocorticoid Antagonists in Heavy Drinkers","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2017-09-26","conditions":"Alcohol Use Disorder","enrollment":65},{"nctId":"NCT05772169","phase":"PHASE4","title":"Study to Determine the Prevalence of Hypercortisolism in Patients With Type 2 Diabetes and Treatment With Korlym® (Mifepristone) (CATALYST)","status":"COMPLETED","sponsor":"Corcept Therapeutics","startDate":"2023-03-31","conditions":"Hypercortisolism, Diabetes Mellitus, Type 2","enrollment":1113},{"nctId":"NCT02243709","phase":"PHASE1, PHASE2","title":"Mifepristone for the Prevention of Relapses of Alcohol Drinking","status":"COMPLETED","sponsor":"Brown University","startDate":"2014-09","conditions":"Alcohol Use Disorders (AUD)","enrollment":32},{"nctId":"NCT06733727","phase":"NA","title":"Letrozole Versus Mifepristone and Misoprostol in Silent Miscarriage","status":"NOT_YET_RECRUITING","sponsor":"The University of Hong Kong","startDate":"2024-12-06","conditions":"Silent Miscarriage","enrollment":884},{"nctId":"NCT05217758","phase":"PHASE2","title":"RESET-medication Glucocorticoid Receptor (GR) Blockade As Disease Modifying Treatment for Depression with Childhood Trauma","status":"COMPLETED","sponsor":"Amsterdam UMC, location VUmc","startDate":"2021-12-09","conditions":"Major Depressive Disorder, Childhood Trauma","enrollment":158},{"nctId":"NCT06689254","phase":"PHASE2","title":"REVERSE: Improving Treatment-resistant Post Traumatic Stress Disorder (PTSD) with Glucocorticoid Receptor (GR) Antagonism","status":"RECRUITING","sponsor":"Christiaan Vinkers","startDate":"2024-11-15","conditions":"Treatment-resistant PTSD","enrollment":60},{"nctId":"NCT06616077","phase":"EARLY_PHASE1","title":"Endometrial Transcript Profile with Progesterone After Post-ovulatory Mifepristone","status":"COMPLETED","sponsor":"Reproductive Health Research Insritute, Chile","startDate":"2022-06-07","conditions":"Endometrial Endocrine Regulation, Progesterone Supplementation in Women After Mifepristone","enrollment":9},{"nctId":"NCT06492889","phase":"PHASE2, PHASE3","title":"Assessing the Efficacy and Acceptability of Two Missed Period Pills Regimens","status":"NOT_YET_RECRUITING","sponsor":"Gynuity Health Projects","startDate":"2024-07-22","conditions":"Pregnancy Early, Pregnancy Related","enrollment":286},{"nctId":"NCT01294319","phase":"PHASE2","title":"Evaluation of Cortisol Resistance in Young Sedentary and Endurance-Trained Men","status":"COMPLETED","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2011-01-24","conditions":"Cortisol Resistance, Negative Feedback, ACTH","enrollment":51},{"nctId":"NCT01862991","phase":"NA","title":"Pre-Operative Effects of Mifepristone on Dilation and Evacuation Services","status":"COMPLETED","sponsor":"Stanford University","startDate":"2013-07","conditions":"Legally Induced Abortion Without Mention of Complication","enrollment":80},{"nctId":"NCT00133705","phase":"PHASE3","title":"Trial of Mifepristone for Fibroids","status":"COMPLETED","sponsor":"University of Rochester","startDate":"2003-07","conditions":"Leiomyoma","enrollment":70},{"nctId":"NCT03052400","phase":"PHASE2","title":"Efficacy of Mifepristone in Males With Type 2 Diabetes Mellitus","status":"TERMINATED","sponsor":"Charles Drew University of Medicine and Science","startDate":"2017-02-03","conditions":"Type 2 Diabetes Mellitus, Insulin Resistance","enrollment":8},{"nctId":"NCT02179749","phase":"PHASE2","title":"Mifepristone Treatment of Alcohol Use Disorder","status":"COMPLETED","sponsor":"The Scripps Research Institute","startDate":"2014-09","conditions":"Alcohol Dependence, Alcohol Use Disorders, Alcohol Abuse","enrollment":103},{"nctId":"NCT03714880","phase":"PHASE2","title":"Cervical Preparation With Mifepristone Prior to Osmotic Dilators","status":"TERMINATED","sponsor":"University of California, Davis","startDate":"2019-04-26","conditions":"Second Trimester Abortion","enrollment":44},{"nctId":"NCT02412618","phase":"PHASE4","title":"Same-Day Mifepristone-Misoprostol Compared to Misoprostol Only for Surgical Abortion Cervical Preparation","status":"COMPLETED","sponsor":"Medstar Health Research Institute","startDate":"2012-09","conditions":"Induced Abortion","enrollment":100},{"nctId":"NCT00698022","phase":"PHASE1","title":"A 4-week Study of Mifepristone in the Prevention of Risperidone-induced Weight Gain in Healthy Male Volunteers","status":"COMPLETED","sponsor":"Corcept Therapeutics","startDate":"2008-11","conditions":"Healthy","enrollment":76},{"nctId":"NCT01898312","phase":"PHASE2","title":"BRCA1/2 and Effect of Mifepristone on the Breast","status":"COMPLETED","sponsor":"Karolinska Institutet","startDate":"2013-09","conditions":"Women With Mutations in the Breast Cancer Susceptibility Genes BRCA1,2","enrollment":45},{"nctId":"NCT00099645","phase":"PHASE1, PHASE2","title":"Anti-HIV Activity and Safety of 3 Different Doses of Mifepristone in HIV Infected People","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections","enrollment":48},{"nctId":"NCT02704481","phase":"PHASE4","title":"Non-surgical Alternatives to Treatment of Failed Medical Abortion","status":"TERMINATED","sponsor":"Gynuity Health Projects","startDate":"2016-06-01","conditions":"Abortion Failure","enrollment":16},{"nctId":"NCT01419535","phase":"PHASE1, PHASE2","title":"Mifepristone Effects on Glucose Intolerance in Obese/Overweight Adults","status":"COMPLETED","sponsor":"Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)","startDate":"2011-11-29","conditions":"Endocrine Disease, Diabetes","enrollment":19},{"nctId":"NCT02620904","phase":"PHASE4","title":"Mifepristone Induction for Fetal Demise","status":"TERMINATED","sponsor":"Montefiore Medical Center","startDate":"2016-07-14","conditions":"Intrauterine Fetal Demise, Fetal Death","enrollment":9},{"nctId":"NCT01333098","phase":"PHASE1, PHASE2","title":"Antiglucocorticoid Therapy for Cognitive Impairment in Late-life Anxiety Disorders","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2012-09","conditions":"Anxiety Disorders","enrollment":15},{"nctId":"NCT03212352","phase":"PHASE4","title":"Comparing Two Medical Treatments for Early Pregnancy Failure.","status":"TERMINATED","sponsor":"Radboud University Medical Center","startDate":"2018-06-27","conditions":"Early Pregnancy Failure","enrollment":342},{"nctId":"NCT03065660","phase":"PHASE3","title":"Mifepristone and Misoprostol Versus Misoprostol Alone in the Medical Management of Missed Miscarriage","status":"COMPLETED","sponsor":"University of Birmingham","startDate":"2017-09-20","conditions":"Missed Miscarriage","enrollment":711},{"nctId":"NCT03774745","phase":"PHASE1, PHASE2","title":"Blocking Mifepristone Action With Progesterone","status":"TERMINATED","sponsor":"University of California, Davis","startDate":"2019-02-11","conditions":"Pregnancy, Unwanted","enrollment":12},{"nctId":"NCT03015701","phase":"PHASE3","title":"S9005 Mifepristone in Meningioma","status":"COMPLETED","sponsor":"SWOG Cancer Research Network","startDate":"1992-08","conditions":"Meningioma","enrollment":193},{"nctId":"NCT03520439","phase":"PHASE2, PHASE3","title":"Evaluation of Therapeutic Effect and Safety of Mifepristone in the Treatment of Adenomyosis","status":"COMPLETED","sponsor":"xinmei zhang","startDate":"2018-05-19","conditions":"Adenomyosis","enrollment":134},{"nctId":"NCT03508635","phase":"PHASE1","title":"CORT125134 Single Ascending Dose (SAD) and Multiple Ascending Dose (MAD)","status":"COMPLETED","sponsor":"Corcept Therapeutics","startDate":"2014-09","conditions":"Healthy","enrollment":130},{"nctId":"NCT03248713","phase":"EARLY_PHASE1","title":"Glucocorticoid Antagonist Treatment for Tobacco Use Disorder","status":"TERMINATED","sponsor":"Yale University","startDate":"2017-11-29","conditions":"Nicotine Dependence","enrollment":8},{"nctId":"NCT01212588","phase":"PHASE2","title":"Preliminary Trial of the Effect of Glucocorticoid Receptor Antagonist on Borderline Personality Disorder (BPD)","status":"TERMINATED","sponsor":"Indiana University","startDate":"2010-09","conditions":"Borderline Personality Disorder","enrollment":22},{"nctId":"NCT02633761","phase":"PHASE3","title":"Mifepristone-misoprostol vs. Misoprostol Alone for Second Trimester Fetal Death","status":"TERMINATED","sponsor":"Gynuity Health Projects","startDate":"2015-04-01","conditions":"Fetal Death","enrollment":200},{"nctId":"NCT02342002","phase":"PHASE4","title":"Mifepristone and Misoprostol Versus Misoprostol Alone for Missed Abortion: A Randomized-controlled Trial","status":"TERMINATED","sponsor":"Gynuity Health Projects","startDate":"2015-01","conditions":"Missed Abortion, Pregnancy","enrollment":416},{"nctId":"NCT01134198","phase":"PHASE2, PHASE3","title":"Investigation of Mifepristone (RU486) on Stress Sensitivity and Relapse Prevention in Cocaine Dependent Patients","status":"COMPLETED","sponsor":"New York State Psychiatric Institute","startDate":"2010-05","conditions":"Cocaine Dependence","enrollment":58},{"nctId":"NCT01493310","phase":"PHASE1","title":"Nab-paclitaxel (Abraxane) With or Without Mifepristone in Patients With Advanced Breast Cancer","status":"COMPLETED","sponsor":"University of Chicago","startDate":"2011-11","conditions":"Male Breast Cancer, Recurrent Breast Cancer, Stage IIIA Breast Cancer","enrollment":9},{"nctId":"NCT03134183","phase":"PHASE4","title":"24-hour Mifepristone and Buccal Versus Mifepristone and Vaginal Misoprostol for Cervical Preparation for D&E","status":"COMPLETED","sponsor":"Virginia Commonwealth University","startDate":"2016-11-19","conditions":"Abortion, Second Trimester","enrollment":70},{"nctId":"NCT01739335","phase":"PHASE2","title":"Novel Therapeutics in Posttraumatic Stress Disorder (PTSD): A Randomized Clinical Trial of Mifepristone","status":"COMPLETED","sponsor":"VA Office of Research and Development","startDate":"2012-11-19","conditions":"Stress Disorders, Post-Traumatic","enrollment":81},{"nctId":"NCT02354170","phase":"PHASE2","title":"Short-Term Oral Mifepristone for Central Serous Chorioretinopathy","status":"COMPLETED","sponsor":"Roger Goldberg, M.D., MBA","startDate":"2015-01","conditions":"Central Serous Chorioretinopathy","enrollment":16},{"nctId":"NCT01490697","phase":"PHASE4","title":"Developing Memory Reconsolidation Blockers as Novel Posttraumatic Stress Disorder (PTSD) Treatments","status":"COMPLETED","sponsor":"Roger K. Pitman, MD","startDate":"2009-03","conditions":"Post-traumatic Stress Disorder","enrollment":34},{"nctId":"NCT00637494","phase":"PHASE3","title":"A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features","status":"TERMINATED","sponsor":"Corcept Therapeutics","startDate":"2008-03","conditions":"Psychotic Depression, Severe Major Depression With Psychotic Features, Psychosis","enrollment":292},{"nctId":"NCT00186056","phase":"NA","title":"Mifepristone in Refractory Depression","status":"COMPLETED","sponsor":"Stanford University","startDate":"2003-01","conditions":"Depression","enrollment":31},{"nctId":"NCT00867360","phase":"PHASE3","title":"Treatment of Psychotic Major Depression With Mifepristone","status":"TERMINATED","sponsor":"Stanford University","startDate":"2005-08","conditions":"Affective Disorders, Psychotic, Depressive Disorder","enrollment":10},{"nctId":"NCT00725270","phase":"PHASE2, PHASE3","title":"Treatment of Schizoaffective Disorder Using Mifepristone","status":"TERMINATED","sponsor":"Stanford University","startDate":"1998-04","conditions":"Psychotic Disorders, Depressive Disorder, Major, Depressive Disorder","enrollment":12},{"nctId":"NCT00285818","phase":"NA","title":"Mifepristone Treatment for Patients With Non-psychotic Major Depressive Disorder Receiving Bilateral ECT","status":"COMPLETED","sponsor":"Stanford University","startDate":"2003-01","conditions":"Depression","enrollment":11},{"nctId":"NCT03044093","phase":"PHASE4","title":"Mifepristone and Misoprostol Compared With Misoprostol Alone for Second Trimester Abortion","status":"UNKNOWN","sponsor":"Rambam Health Care Campus","startDate":"2017-01","conditions":"Second Trimester Abortion","enrollment":200},{"nctId":"NCT00691067","phase":"PHASE4","title":"A Controlled Trial of Mifepristone in Gulf War Veterans With Chronic Multisymptom Illness","status":"COMPLETED","sponsor":"Bronx Veterans Medical Research Foundation, Inc","startDate":"2008-05","conditions":"Chronic Multisymptom Illness in Gulf War Veterans","enrollment":65},{"nctId":"NCT01548417","phase":"PHASE2","title":"Medication Development in Alcoholism: Investigating Glucocorticoid Antagonists","status":"COMPLETED","sponsor":"The Scripps Research Institute","startDate":"2012-03","conditions":"Alcoholism","enrollment":56},{"nctId":"NCT00219778","phase":"PHASE2","title":"A Study on the Efficacy of 10 mg Oral Mifepristone for the Treatment of Symptomatic Uterine Leiomyomas","status":"TERMINATED","sponsor":"Poitiers University Hospital","startDate":"2004-12","conditions":"Leiomyoma","enrollment":20},{"nctId":"NCT00554177","phase":"PHASE1","title":"A Clinical Trial for Post Traumatic Stress Disorder","status":"COMPLETED","sponsor":"Antonia New","startDate":"2007-09","conditions":"Post Traumatic Stress Disorder (PTSD)","enrollment":5},{"nctId":"NCT01931657","phase":"PHASE2","title":"Pretreatment With Mifepristone Prior to Mirena Insertion","status":"COMPLETED","sponsor":"Karolinska Institutet","startDate":"2013-08","conditions":"Women in Need of Long Acting Reversibel Cntraception With the Intrauterine Levonorgestrel Releasing System, Mirena","enrollment":60},{"nctId":"NCT01751087","phase":"NA","title":"Cervical Preparation Before Dilation and Evacuation","status":"COMPLETED","sponsor":"Planned Parenthood League of Massachusetts","startDate":"2013-01","conditions":"Abortion, Induced","enrollment":300},{"nctId":"NCT02297048","phase":"PHASE4","title":"Monocentric STUDY, Randomised Double Blinded (Healthy Subjects, or Transversal (Patients With Gitelman Syndrome)","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2014-07","conditions":"Gitelman Syndrome, Potassium Depletion","enrollment":26},{"nctId":"NCT00579475","phase":"PHASE1","title":"The Effect of Mifepristone on Uterine Fibroids and Breast Tissue","status":"COMPLETED","sponsor":"Karolinska Institutet","startDate":"2004-11","conditions":"Uterine Fibroids","enrollment":30},{"nctId":"NCT00833339","phase":"PHASE2","title":"Trial of Mifepristone in Combat Veterans With Posttraumatic Stress Disorder","status":"UNKNOWN","sponsor":"James J. Peters Veterans Affairs Medical Center","startDate":"2008-05","conditions":"Posttraumatic Stress Disorder","enrollment":80},{"nctId":"NCT02271958","phase":"PHASE2, PHASE3","title":"Mifepristone 2.5, 5, 10 mg Versus Placebo in the Treatment of Endometriosis","status":"COMPLETED","sponsor":"Mediterranea Medica S. L.","startDate":"2010-11","conditions":"Endometriosis","enrollment":360},{"nctId":"NCT01768299","phase":"PHASE4","title":"Medical Abortion With Mifepristone + Misoprostol (13 - 22 Weeks)","status":"COMPLETED","sponsor":"Gynuity Health Projects","startDate":"2013-02","conditions":"Complete Uterine Evacuation After Use of Study Drugs","enrollment":504},{"nctId":"NCT00969982","phase":"NA","title":"Mifepristone Plus Misoprostol Versus Misoprostol Alone for 2nd Trimester Abortion (14 - 21 Weeks Last Menstrual Period (LMP))","status":"COMPLETED","sponsor":"Gynuity Health Projects","startDate":"2009-06","conditions":"Abortion, Induced","enrollment":238},{"nctId":"NCT00784186","phase":"NA","title":"Mifepristone and Misoprostol Versus Misoprostol Alone for Mid-trimester Termination of Pregnancy (14 - 21 Weeks LMP): A Randomized-controlled Double-blinded Trial","status":"COMPLETED","sponsor":"Gynuity Health Projects","startDate":"2008-08","conditions":"Abortion, Induced","enrollment":120},{"nctId":"NCT00359125","phase":"PHASE2","title":"RU-486 in the Treatment of Bipolar Depression","status":"WITHDRAWN","sponsor":"University of British Columbia","startDate":"2006-07","conditions":"Bipolar Depression","enrollment":""},{"nctId":"NCT00680394","phase":"NA","title":"Comparing Two Regimens for Medical Abortion: Mifepristone+Misoprostol Versus Misoprostol Alone","status":"COMPLETED","sponsor":"Gynuity Health Projects","startDate":"2007-07","conditions":"Pregnancy Termination","enrollment":440},{"nctId":"NCT00997074","phase":"PHASE3","title":"Efficacy Study of Prophylactic Ibuprofen Versus Placebo on Pain Relief and Success Rates of Medical Abortion","status":"COMPLETED","sponsor":"Sheba Medical Center","startDate":"2009-10","conditions":"Pain, Pregnancy","enrollment":61},{"nctId":"NCT00128479","phase":"PHASE3","title":"A United States Study of the Safety and Tolerability of Corlux for Psychotic Symptoms in Psychotic Major Depression","status":"COMPLETED","sponsor":"Corcept Therapeutics","startDate":"2004-09","conditions":"Major Depressive Disorder, Psychotic Disorders","enrollment":443},{"nctId":"NCT00146523","phase":"PHASE3","title":"An International Study of the Safety and Tolerability of Corlux for Psychotic Symptoms in Psychotic Major Depression","status":"COMPLETED","sponsor":"Corcept Therapeutics","startDate":"2005-05","conditions":"Major Depressive Disorder","enrollment":247},{"nctId":"NCT00130676","phase":"PHASE3","title":"A United States Study of Corlux for Psychotic Symptoms in Psychotic Major Depression","status":"COMPLETED","sponsor":"Corcept Therapeutics","startDate":"2004-09","conditions":"Major Depressive Disorder, Psychotic Disorders","enrollment":257},{"nctId":"NCT00957346","phase":"PHASE3","title":"Mifepristone and Misoprostol Versus Misoprostol Alone for Mid-trimester Termination of Pregnancy (14-21 Weeks LMP)","status":"TERMINATED","sponsor":"Gynuity Health Projects","startDate":"2011-02","conditions":"Abortion, Induced","enrollment":20},{"nctId":"NCT00468299","phase":"NA","title":"MiMi: A Randomized Trial of Mifepristone and Misoprostol for Treatment of Early Pregnancy Failure","status":"TERMINATED","sponsor":"Boston University","startDate":"2007-04","conditions":"Early Pregnancy Failure, Miscarriage, Fetal Demise","enrollment":16},{"nctId":"NCT00352911","phase":"PHASE2","title":"Antiviral Activity and Safety of Mifepristone at 2 Doses in HIV-1 Infected Subjects","status":"COMPLETED","sponsor":"VGX Pharmaceuticals, LLC","startDate":"2006-07","conditions":"HIV Infections","enrollment":19},{"nctId":"NCT00105105","phase":"PHASE2","title":"Mifepristone as Adjunctive Therapy in Alzheimer's Disease","status":"TERMINATED","sponsor":"Corcept Therapeutics","startDate":"2003-04","conditions":"Alzheimer's Disease","enrollment":160},{"nctId":"NCT00255177","phase":"PHASE2","title":"Antiviral Activity and Safety of 3 Different Doses of Mifepristone in Hepatitis C Infected Patients","status":"COMPLETED","sponsor":"VGX Pharmaceuticals, LLC","startDate":"2005-11","conditions":"Hepatitis C Virus Infection","enrollment":44},{"nctId":"NCT00382538","phase":"NA","title":"Mifepristone and Mid-Trimester Termination of Pregnancy","status":"COMPLETED","sponsor":"Boston University","startDate":"2005-03","conditions":"Abortion, Induced, Abortion, Second Trimester","enrollment":64},{"nctId":"NCT00455442","phase":"PHASE2","title":"A Two-Week Study of the Efficacy and Safety of Mifepristone in the Prevention of Olanzapine-Induced Weight Gain","status":"COMPLETED","sponsor":"Corcept Therapeutics","startDate":"2007-03","conditions":"Weight-Gain Prevention","enrollment":57}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":278,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Placebo mifepristone","genericName":"Placebo mifepristone","companyName":"Gynuity Health Projects","companyId":"gynuity-health-projects","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}